Targeting menopausal hot flushes with non-hormonal treatment

Description

In this Product Explainer, Gynaecologist Prof Rod Baber AM presents the clinical data for fezolinetant, including its impact on hot flush frequency and severity, tolerability profile, and considerations for use in clinical practice (6 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Jacob George

Prof Jacob George

Fatty Liver, CV Risk, and Post-Menopause

Prof Sebastian King

Prof Sebastian King

Paediatric Constipation & Related Issues

Hayley Ryan

Hayley Ryan

Management of Skin Tear in General Practice

Dr Katherine Spira

Dr Katherine Spira

Migraine vs Chronic Daily Headache

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Rodney Baber AM

expert

Prof Rodney Baber AM

Obstetrician and Gynaecologist; Clinical Professor, Obstetrics and Gynaecology, The University of Sydney; Past President, International Menopause Society and Australasian Menopause Society

Date published: 20 October 2026